GlassScriptPhysician profile
Rose S Southerland
NPI 1790823334
$5,097.03
in general payments reported to CMS, 2019-2025
31 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what 89% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $187 · 2021: $781 · 2022: $587 · 2023: $614 · 2024: $1,432 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,362.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,156.27 | 2024-2025 | Krystexxa, Kyprolis |
| Horizon Therapeutics Plc | $561.21 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $497.05 | 2019-2025 | Apligraf, Puraply Wound Matrix, Affinity |
| Paratek Pharmaceuticals, INC. | $436.05 | 2021-2025 | Nuzyra |
| Smith+Nephew, INC. | $289.81 | 2020-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Kerecis Limited | $242.78 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Convatec INC. | $205.15 | 2024-2025 | |
| Melinta Therapeutics, LLC | $196.14 | 2019-2023 | Orbactiv, Kimyrsa |
| Nevro Corp. | $177.10 | 2022-2024 | Senza |
| Globus Medical, INC. | $150.86 | 2025 | Senza |
| In2bones USA, LLC | $143.69 | 2022 | |
| Ossio INC | $113.88 | 2023 | |
| Bioventus LLC | $99.08 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Sanara Medtech INC. | $90.90 | 2025 | Celleraterx |
| Boston Scientific Corporation | $83.49 | 2023-2025 | Wavewriter Alpha Prime 16 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forma Medical | $69.76 | 2024 | Optimalakin |
| Medtronic, INC. | $66.46 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Abbvie INC. | $65.48 | 2025 | |
| Linvatec Corporation | $64.53 | 2023 | 5ms |
| Ucb, INC. | $63.00 | 2019 | |
| Novo Nordisk INC | $62.06 | 2020-2024 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $60.04 | 2021-2024 | Octrode, Eterna |
| Azurity Pharmaceuticals, INC. | $38.03 | 2025 | Alvesco |
| Orthofix Medical, INC. | $33.57 | 2023 | Cervical-Stim, Physio-Stim |
| Cashflow Solutions, LLC | $30.88 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Grt US Holding, INC. | $25.23 | 2022 | |
| Mimedx Group, INC. | $18.29 | 2025 | |
| Kci USA, INC. | $15.40 | 2019 | |
| International Rehabilitative Sciences, INC | $14.44 | 2025 | Rs-4i Plus With Intersperse |
| Arbor Pharmaceuticals, INC. | $13.40 | 2019 | |
| Zyla Life Sciences, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Southerland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.